MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0039911
D-Cure Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹45.43 Lakh
▲ 16% YoY
Net loss · FY 2024
₹46.08 Lakh
Net margin -101.4%
EBITDA · FY 2024
-₹45.79 Lakh
EBITDA margin -100.8%
Authorised capital
₹21 Lakh
Registered with MCA
Paid-up capital
₹2.1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Employees · EPFO
16
Provident fund records
Directors on board
3
As per MCA filings
About D-Cure Pharmaceuticals Private Limited
Data last updated:
D-Cure Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2015PTC277682. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹21 Lakh and a paid-up capital of ₹2.1 Lakh. It is led by directors including Nayab Khatoon and Manju Bala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 101 First Floor Chaudhary Complex 9 Veer Savarkar Block Shakarpur, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹45.43 Lakh, a growth of 16% compared to the previous year. For the same year it recorded a net loss of ₹46.08 Lakh (net margin -101.4%) and EBITDA of -₹45.79 Lakh (EBITDA margin -100.8%).
The company has about 16 employees on its provident fund (EPFO) records.
D-Cure Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0039911). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website d-cure.in.
Company details
CIN U74999DL2015PTC277682
Registration Number 277682
Incorporation Date 09 March 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0039911
Recognitions & Rankings of D-Cure Pharmaceuticals
Contact details
D-Cure Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is d-cure.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address101 First Floor Chaudhary Complex 9 Veer Savarkar Block Shakarpur, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of D-Cure Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
D-Cure Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of D-Cure Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of D-Cure Pharmaceuticals Private Limited, buy the company report.
Financials of D-Cure Pharmaceuticals Private Limited
FY 2024 filings availableD-Cure Pharmaceuticals Private Limited reported revenue of ₹45.43 Lakh (up 16% YoY) for FY 2024.
Revenue · FY 2024
₹45.43 Lakh ▲ 16%
Net loss · FY 2024
₹46.08 Lakh margin -101.4%
EBITDA · FY 2024
-₹45.79 Lakh margin -100.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
EBITDA CAGR growth
1 year
▲ 59%
3 years · compounded
▼ 671%
5 years · compounded
▼ 241%
Revenue rose 16% in the latest year. EBITDA rose 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹45.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹46.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -100.8% | ||||
| Net Profit Margin | -101.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of D-Cure Pharmaceuticals Private Limited, buy the company report.
Board of directors of D-Cure Pharmaceuticals Private Limited
D-Cure Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nayab Khatoon | Director | 09 Sep 2020 | 6 Years 1 Months | Current |
| Manju Bala | Director | 09 Sep 2020 | 6 Years 1 Months | Current |
| Vijay Laxmi Dinkar | Director | 05 Jan 2022 | 4 Years 9 Months | Current |
Peer comparison
D-Cure Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Semicon Pharmaceuticals Private Limited | ₹45.55 Lakh (FY 2024) | 648.0% | Hyderabad, Telangana, India | |||
| Cynosis Pharmaceuticals Private Limited | ₹45.48 Lakh (FY 2023) | 446.0% | Ramol, Gujarat, India | |||
| Hamson Pharmaceuticals and Chemicals Private Limited | ₹45.48 Lakh (FY 2023) | 68.0% | Pune, Maharashtra, India | |||
| D-Cure Pharmaceuticals Private Limitedthis company | ₹45.43 Lakh (FY 2024) | -₹46.08 Lakh | -101.4% | 16.0% | 16 | Delhi, India |
To see the full peer comparison of D-Cure Pharmaceuticals Private Limited, buy the company report.
Auditor
D-Cure Pharmaceuticals Private Limited is audited by BHAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHAL & ASSOCIATES | FY 2023 | 073884 |
Shareholding
The shareholding of D-Cure Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of D-Cure Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving D-Cure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for D-Cure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
D-Cure Pharmaceuticals Private Limited has a workforce of 16 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
16
Active EPFO establishments
1
Employee growth
-20%
GST
D-Cure Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of D-Cure Pharmaceuticals Private Limited, buy the company report.
Recent activity
D-Cure Pharmaceuticals Private Limited has 7 board changes on record since 2020: 3 appointments and 4 cessations. The latest: Vijay Laxmi Dinkar was appointed as Director on 05 Jan 2022.
AGM
D-Cure Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
D-Cure Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Vijay Laxmi Dinkar was appointed as Director.
Ceased
Manju Bala ceased to be Director.
Ceased
Nayab Khatoon ceased to be Director.
Appointed
Manju Bala was appointed as Director.
Ceased
Manoj Kumar ceased to be Director.
Ceased
Mohd Waseem ceased to be Director.
Appointed
Nayab Khatoon was appointed as Director.
Incorporation
09 Mar 2015
D-Cure Pharmaceuticals Private Limited was registered on 09 Mar 2015 with Roc Delhi & aged 11 years 7 months as per MCA records.
Frequently asked questions
D-Cure Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 March 2015 (11+ years old) and is registered under CIN U74999DL2015PTC277682.
D-Cure Pharmaceuticals has 3 current directors:
- Nayab Khatoon - Director
- Manju Bala - Director
- Vijay Laxmi Dinkar - Director
The latest financial statements of D-Cure Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. D-Cure Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of D-Cure Pharmaceuticals is U74999DL2015PTC277682. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
D-Cure Pharmaceuticals was incorporated on 09 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of D-Cure Pharmaceuticals by revenue are Semicon Pharmaceuticals Private Limited, Cynosis Pharmaceuticals Private Limited, Hamson Pharmaceuticals and Chemicals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Vijay Laxmi Dinkar was appointed as Director on 05 Jan 2022. Manju Bala ceased to be Director on 15 Dec 2021. Nayab Khatoon ceased to be Director on 15 Dec 2021. D-Cure Pharmaceuticals has 7 board changes on record in total.
Yes, D-Cure Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0039911).
D-Cure Pharmaceuticals can be reached through the website d-cure.in. Its registered office is in Delhi, India.
The registered office of D-Cure Pharmaceuticals is at 101 First Floor Chaudhary Complex 9 Veer Savarkar Block Shakarpur, Delhi, India – 110092.